(Q39625460)

13 September 2017

Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2. (English)

1 reference

13 September 2017

1 reference

3

Mary Tagliaferri

1 reference

13 September 2017

Sreenivasan Paruthiyil

1

1 reference

13 September 2017

Aleksandra Cvoro

2

1 reference

13 September 2017

Isaac Cohen

4

1 reference

13 September 2017

Emma Shtivelman

5

1 reference

13 September 2017

Dale C Leitman

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

Breast Cancer Research and Treatment

13 September 2017

1 reference

13 September 2017

129

1 reference

13 September 2017

777-784

1 reference

13 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-010-1273-5

13 September 2017

0 references

cites work

Estrogen receptor and breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Optimizing the antihormonal treatment and prevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

ER beta inhibits proliferation and invasion of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

The mammalian anti-proliferative BTG/Tob protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Cell cycle-dependent regulation of the cyclin B1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Estrogen receptor pathways to AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

Genome-wide analysis of estrogen receptor binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1273-5

10.1007/S10549-010-1273-5

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference